Anheuser-Busch InBev SA/NV’s (BUD) “Buy” Rating Reiterated at Deutsche Bank Aktiengesellschaft

Deutsche Bank Aktiengesellschaft restated their buy rating on shares of Anheuser-Busch InBev SA/NV (NYSE:BUD) in a report issued on Thursday.

Several other equities research analysts have also commented on the stock. TD Cowen boosted their price objective on shares of Anheuser-Busch InBev SA/NV from $85.00 to $89.00 and gave the stock a “hold” rating in a research note on Friday, June 26th. Morgan Stanley decreased their target price on shares of Anheuser-Busch InBev SA/NV from $86.50 to $84.50 and set an “overweight” rating for the company in a research note on Thursday, July 2nd. Wells Fargo & Company lifted their target price on shares of Anheuser-Busch InBev SA/NV from $93.00 to $97.00 and gave the company an “overweight” rating in a report on Friday, July 31st. Weiss Ratings cut Anheuser-Busch InBev SA/NV from a “hold (c+)” rating to a “hold (c)” rating in a research report on Friday, July 17th. Finally, JPMorgan Chase & Co. restated a “buy” rating on shares of Anheuser-Busch InBev SA/NV in a research note on Tuesday, June 30th. Twelve equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat, Anheuser-Busch InBev SA/NV currently has an average rating of “Moderate Buy” and an average price target of $91.08.

Anheuser-Busch InBev SA/NV Stock Performance

Shares of Anheuser-Busch InBev SA/NV stock opened at $77.96 on Thursday. The company has a current ratio of 0.66, a quick ratio of 0.50 and a debt-to-equity ratio of 0.68. The firm has a market capitalization of $157.43 billion, a P/E ratio of 16.52, a P/E/G ratio of 1.12 and a beta of 0.59. The business has a fifty day simple moving average of $80.31 and a two-hundred day simple moving average of $78.42. Anheuser-Busch InBev SA/NV has a 12 month low of $58.44 and a 12 month high of $86.60.

Anheuser-Busch InBev SA/NV (NYSE:BUD) last announced its earnings results on Wednesday, July 29th. The consumer goods maker reported $1.21 EPS for the quarter, beating analysts’ consensus estimates of $1.09 by $0.12. The firm had revenue of $16.66 billion for the quarter, compared to analysts’ expectations of $16.23 billion. Anheuser-Busch InBev SA/NV had a net margin of 14.90% and a return on equity of 16.42%. The company’s quarterly revenue was up 11.0% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.98 EPS. On average, equities analysts forecast that Anheuser-Busch InBev SA/NV will post 4.38 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Anheuser-Busch InBev SA/NV

Several institutional investors have recently modified their holdings of the business. Goldman Sachs Group Inc. increased its holdings in Anheuser-Busch InBev SA/NV by 1.1% in the 4th quarter. Goldman Sachs Group Inc. now owns 4,009,863 shares of the consumer goods maker’s stock worth $256,792,000 after buying an additional 42,009 shares in the last quarter. Wellington Management Group LLP lifted its stake in Anheuser-Busch InBev SA/NV by 10,464.1% during the 2nd quarter. Wellington Management Group LLP now owns 3,190,248 shares of the consumer goods maker’s stock valued at $262,876,000 after acquiring an additional 3,160,049 shares during the period. Renaissance Technologies LLC lifted its stake in Anheuser-Busch InBev SA/NV by 64.7% during the 1st quarter. Renaissance Technologies LLC now owns 810,874 shares of the consumer goods maker’s stock valued at $56,250,000 after acquiring an additional 318,600 shares during the period. First Trust Advisors LP boosted its holdings in shares of Anheuser-Busch InBev SA/NV by 5.1% during the 1st quarter. First Trust Advisors LP now owns 601,440 shares of the consumer goods maker’s stock valued at $41,722,000 after acquiring an additional 29,124 shares during the last quarter. Finally, NewEdge Advisors LLC boosted its holdings in shares of Anheuser-Busch InBev SA/NV by 7,474.5% during the 2nd quarter. NewEdge Advisors LLC now owns 522,643 shares of the consumer goods maker’s stock valued at $43,066,000 after acquiring an additional 515,743 shares during the last quarter. 5.53% of the stock is owned by hedge funds and other institutional investors.

Key Headlines Impacting Anheuser-Busch InBev SA/NV

Here are the key news stories impacting Anheuser-Busch InBev SA/NV this week:

• Positive Sentiment: Jefferies maintained its Buy rating on Anheuser-Busch InBev, reinforcing the view that the brewer’s earnings and growth outlook remain attractive. Jefferies Buy Rating Article
• Positive Sentiment: RBC also retained its Buy rating, adding to the positive analyst consensus around BUD. RBC Buy Rating Article
• Positive Sentiment: JPMorgan, Bank of America, Deutsche Bank, Jefferies and UBS each reaffirmed Buy ratings, signaling continued confidence from a broad group of Wall Street analysts. The favorable view is consistent with the company’s latest reported quarter, when earnings and revenue exceeded consensus estimates and revenue grew year over year.
• Neutral Sentiment: An article discussing Vanguard bond ETFs BSV and VCIT is not directly related to Anheuser-Busch InBev’s business or outlook and is unlikely to materially affect BUD. Bond ETF Article
• Negative Sentiment: Barclays initiated or reiterated a Hold rating, offering a more cautious assessment than the cluster of Buy recommendations and potentially limiting near-term upside expectations. Barclays Hold Rating Article

Anheuser-Busch InBev SA/NV Company Profile

Anheuser-Busch InBev SA/NV is a global brewing and beverage company headquartered in Leuven, Belgium. The company produces, markets and distributes beer and other alcoholic and nonalcoholic beverages through a broad portfolio of international, regional and local brands.

Its leading brands include Budweiser, Bud Light, Corona, Stella Artois, Michelob ULTRA, Beck’s, Hoegaarden and Leffe. AB InBev also offers a range of craft, premium, flavored and alcohol-free beverages, serving consumers through retail, hospitality and e-commerce channels.

The company was formed in 2008 through the combination of InBev and Anheuser-Busch, bringing together Anheuser-Busch’s U.S.